Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for prevention of memory deficit induced by electroconvulsive therapy
IRCT2016060628309N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of naltrexone in major depressive episode (MDE), bipolar disorder (BD) and dysmnesia, sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2012; status: completed.
02
Drugs
naltrexone
03
Conditions
major depressive episode (MDE)bipolar disorder (BD)dysmnesia
Beyond the preview
Go deeper on IRCT2016060628309N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016060628309N1.